{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,30]],"date-time":"2026-10-30T14:36:58Z","timestamp":1793371018584,"version":"4.5.0"},"reference-count":5,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jaad.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of the American Academy of Dermatology"],"published-print":{"date-parts":[[2026,9]]},"DOI":"10.1016\/j.jaad.2026.09.025","type":"journal-article","created":{"date-parts":[[2026,9,17]],"date-time":"2026-09-17T16:18:32Z","timestamp":1789661912000},"update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["A new era of photoprotection in the United States: Why the Food and Drug Administration's approval of bemotrizinol matters"],"prefix":"10.1016","author":[{"given":"Hannah E.","family":"Amin","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rafey A.","family":"Rehman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Albert E.","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wasey A.","family":"Rehman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hao","family":"Feng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brett","family":"Sloan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jane M.","family":"Grant-Kels","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jaad.2026.09.025_bib1","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1016\/j.jdin.2026.06.003","article-title":"Bemotrizinol and the modernization of US sunscreen regulation","volume":"28","author":"Shaikh","year":"2026","journal-title":"JAAD Int"},{"key":"10.1016\/j.jaad.2026.09.025_bib2","doi-asserted-by":"crossref","first-page":"891","DOI":"10.1016\/j.jaad.2026.04.1970","article-title":"Pending Food and Drug Administration approval of bemotrizinol: a potential turning point for United States sunscreen formulation","volume":"95","author":"Wang","year":"2026","journal-title":"J Am Acad Dermatol"},{"issue":"5","key":"10.1016\/j.jaad.2026.09.025_bib3","doi-asserted-by":"crossref","DOI":"10.1111\/phpp.70032","article-title":"Modernizing U.S. sunscreen regulations: how newer filters can improve public health","volume":"41","author":"Turner","year":"2025","journal-title":"Photodermatol Photoimmunol Photomed"},{"issue":"2","key":"10.1016\/j.jaad.2026.09.025_bib4","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1017\/jme.2021.46","article-title":"Over-the-Counter Monograph Safety, Innovation, and Reform Act","volume":"49","author":"Gardiner","year":"2021","journal-title":"J Law Med Ethics"},{"issue":"3","key":"10.1016\/j.jaad.2026.09.025_bib5","doi-asserted-by":"crossref","first-page":"632","DOI":"10.1016\/j.jaad.2022.11.039","article-title":"Ultraviolet filters in the United States and European Union: a review of safety and implications for the future of US sunscreens","volume":"88","author":"Pantelic","year":"2023","journal-title":"J Am Acad Dermatol"}],"container-title":["Journal of the American Academy of Dermatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0190962226035292?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0190962226035292?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,30]],"date-time":"2026-10-30T14:27:50Z","timestamp":1793370470000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0190962226035292"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9]]},"references-count":5,"alternative-id":["S0190962226035292"],"URL":"https:\/\/doi.org\/10.1016\/j.jaad.2026.09.025","relation":{},"ISSN":["0190-9622"],"issn-type":[{"value":"0190-9622","type":"print"}],"subject":[],"published":{"date-parts":[[2026,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A new era of photoprotection in the United States: Why the Food and Drug Administration's approval of bemotrizinol matters","name":"articletitle","label":"Article Title"},{"value":"Journal of the American Academy of Dermatology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jaad.2026.09.025","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 American Academy of Dermatology, Inc. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}